mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy

NCT05362617 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

328

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: FOLFIRI

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University